Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPENTOLATE Cause Cardiovascular disorder? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Cardiovascular disorder have been filed in association with CYCLOPENTOLATE (Cyclopentolate Hydrochloride). This represents 0.9% of all adverse event reports for CYCLOPENTOLATE.

5
Reports of Cardiovascular disorder with CYCLOPENTOLATE
0.9%
of all CYCLOPENTOLATE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Cardiovascular disorder From CYCLOPENTOLATE?

Of the 5 reports.

Is Cardiovascular disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOPENTOLATE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOPENTOLATE Cause?

Mydriasis (55) Eye pain (41) Vision blurred (39) Drug ineffective (38) Keratopathy (37) Visual impairment (36) Headache (34) Nausea (32) Confusional state (31) Toxic anterior segment syndrome (31)

What Other Drugs Cause Cardiovascular disorder?

ADALIMUMAB (482) ACETAMINOPHEN\PROPOXYPHENE (453) TESTOSTERONE (434) PROPOXYPHENE (399) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (354) CRESTOR (319) TESTOSTERONE CYPIONATE (221) LEVOFLOXACIN (213) METHOTREXATE (206) RITUXIMAB (193)

Which CYCLOPENTOLATE Alternatives Have Lower Cardiovascular disorder Risk?

CYCLOPENTOLATE vs CYCLOPHOSPHAMIDE CYCLOPENTOLATE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPENTOLATE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPENTOLATE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPENTOLATE vs CYCLOSERINE

Related Pages

CYCLOPENTOLATE Full Profile All Cardiovascular disorder Reports All Drugs Causing Cardiovascular disorder CYCLOPENTOLATE Demographics